Is it contraindicated to perform a pulmonary function test (PFT) after an intra‑articular steroid injection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

No Contraindication to Pulmonary Function Testing After Intra-Articular Steroid Injection

There is no contraindication to performing pulmonary function tests (PFTs) after intra-articular steroid injections. The available evidence does not identify intra-articular corticosteroid injections as a contraindication to lung function testing.

Evidence-Based Reasoning

Established Contraindications to PFT

The 2011 comprehensive review on contraindications for lung function testing 1 identifies high-risk contraindications as:

  • Cardiovascular complications: myocardial infarction, pulmonary embolism, ascending aortic aneurysm
  • Recent major surgery: thoracic, abdominal, or head surgery (typically wait <3 weeks with modern techniques, down from the previous 6-week recommendation)

Intra-articular steroid injections are not mentioned among any contraindications in the established pulmonary function testing guidelines 2, 1.

Systemic Effects Are Not Contraindications

While intra-articular corticosteroids do have systemic effects, these do not preclude PFT performance:

  • HPA axis suppression occurs with serum cortisol decreasing within hours, reaching nadir at 24-48 hours, and recovering in 1-4 weeks 3
  • Transient hyperglycemia may occur in diabetic patients over a few days 3
  • Secondary adrenal insufficiency can develop but is a metabolic concern, not a pulmonary testing contraindication 4

Direct Evidence from Steroid Injection Studies

Research examining lung function after steroid injections supports safety:

  • A 2022 randomized trial of cervical epidural steroid injections specifically measured PFTs at 30 minutes post-injection and found no significant changes in pulmonary function 5
  • Studies using intra-articular steroids in horses with severe asthma showed the injections actually improved lung function rather than causing harm 6

Clinical Approach

You can proceed with PFT immediately after intra-articular steroid injection without delay. The timing considerations for PFT relate to:

  • Avoiding testing immediately after forced expiratory maneuvers (which can affect subsequent tidal breathing) 2
  • Withholding bronchodilators if assessing baseline function 2
  • Maintaining consistent time of day for serial measurements 2

Important Caveats

  • If the patient has undergone joint surgery (not just injection), standard post-surgical waiting periods apply based on the invasiveness of the procedure 1
  • The systemic corticosteroid effects from the injection may theoretically influence inflammatory markers but do not affect the mechanical aspects of performing spirometry or other PFTs
  • Recent comprehensive guidelines on corticosteroid joint injections 7 do not list PFT as a contraindication or precaution

The absence of any mention of PFT contraindication in multiple authoritative sources 2, 1, 7, combined with direct evidence showing no pulmonary function changes post-injection 5, provides strong support for proceeding with testing without delay.

References

2
Guideline

general considerations for lung function testing.

European Respiratory Journal, 2005

Related Questions

If a patient has a documented allergy to oral corticosteroids, can she be treated with a topical corticosteroid cream?
Can corticosteroids be used to treat crackles and rhonchi?
Can a repeat course of antenatal corticosteroids for fetal lung maturity be administered one week after the previous course?
How long must a child discontinue systemic corticosteroids before allergy testing?
Is it appropriate to give a systemic steroid injection for a patient with persistent knee pain after a prior intra‑articular corticosteroid injection?
In an inpatient who is fasting with a blood glucose of 201 mg/dL and is currently receiving insulin glargine (Lantus) 10 units nightly, what recommendations should be made for the Lantus dosing?
What is the recommended diagnostic work‑up and initial management for a patient with hypercalcemia, renal dysfunction, macrocytic anemia, thrombocytopenia, lymphopenia, elevated total protein, and low albumin?
What is the appropriate rehydration fluid for a hemodynamically stable patient with mild hyponatremia (serum sodium 133.9 mEq/L), hypokalemia (serum potassium 2.40 mEq/L), and low serum chloride (94.8 mEq/L)?
Given a total leukocyte count of 45,400/µL with neutrophils 75%, lymphocytes 3%, myelocytes 2%, metamyelocytes 3%, band forms 16%, platelet count 185,000/µL, erythrocyte sedimentation rate 120 mm/hr, packed cell volume 22.9%, mean corpuscular volume 93.1 fL, and mean corpuscular hemoglobin concentration 36.6 g/dL, what is the interpretation?
Does an intra-articular steroid injection affect the post-bronchodilator response in pulmonary function testing?
Is terbinafine safe for use in lactating mothers, and what are the recommendations for oral versus topical therapy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.